|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18,422.80 INR | -1.87% |
|
-5.60% | +21.28% |
| Market Cap | 236B 2.45B 2.14B 1.98B 1.82B 3.44B 3.51B 23.66B 9.3B 116B 9.22B 9.02B 399B | P/E 2027 * |
56.4x | P/E 2028 * | 40.9x |
|---|---|---|---|---|---|
| Enterprise Value | 239B 2.48B 2.17B 2B 1.85B 3.48B 3.56B 23.95B 9.42B 117B 9.33B 9.13B 403B | EV / Sales 2027 * |
10.4x | EV / Sales 2028 * | 8.57x |
| Free-Float |
62.24% | Yield 2027 * |
0.07% | Yield 2028 * | 0.1% |
Last Transcript: Neuland Laboratories Limited
| 1 day | -1.87% | ||
| 1 week | -5.60% | ||
| Current month | -1.11% | ||
| 1 month | +8.37% | ||
| 3 months | +20.40% | ||
| 6 months | +30.94% | ||
| Current year | +21.28% |
| 1 week | 18,041.55 | 19,539 | |
| 1 month | 17,032.7 | 20,072 | |
| Current year | 11,500 | 20,072 | |
| 1 year | 11,500 | 20,072 | |
| 3 years | 3,100.05 | 20,072 | |
| 5 years | 965.85 | 20,072 | |
| 10 years | 247.3 | 20,072 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 46 | 01/04/2026 | |
Abhijit Majumdar
DFI | Director of Finance/CFO | - | 23/11/2022 |
Ajitabh Singh
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 01/08/2025 | |
| Director/Board Member | 80 | 31/10/2022 | |
| Director/Board Member | 82 | 12/02/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.87% | -5.60% | +27.09% | +526.35% | 2.45B | ||
| +0.85% | -0.80% | +54.84% | +163.70% | 1,051B | ||
| +1.23% | -1.53% | +55.26% | +59.07% | 609B | ||
| +0.04% | +2.58% | +32.96% | +88.75% | 450B | ||
| +0.78% | -0.71% | +30.04% | +24.61% | 330B | ||
| +1.41% | +0.58% | +33.92% | +47.20% | 284B | ||
| -0.27% | -1.87% | +22.13% | +23.47% | 263B | ||
| -1.76% | +2.37% | -22.19% | -38.45% | 223B | ||
| -1.42% | +0.80% | +22.81% | +60.77% | 198B | ||
| -1.48% | +3.43% | +23.42% | +73.31% | 167B | ||
| Average | -0.29% | -0.07% | +28.03% | +102.88% | 357.75B | |
| Weighted average by Cap. | +0.21% | +0.02% | +37.74% | +81.80% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 23.09B 240M 210M 193M 178M 336M 343M 2.31B 909M 11.31B 900M 881M 38.93B | 27.8B 289M 252M 233M 215M 404M 413M 2.78B 1.09B 13.61B 1.08B 1.06B 46.87B |
| Net income | 4.21B 43.71M 38.2M 35.25M 32.49M 61.24M 62.6M 421M 166M 2.06B 164M 161M 7.1B | 5.81B 60.29M 52.68M 48.62M 44.81M 84.46M 86.34M 581M 229M 2.84B 226M 221M 9.79B |
| Net Debt | 2.94B 30.5M 26.66M 24.6M 22.67M 42.73M 43.68M 294M 116M 1.44B 115M 112M 4.95B | 1.92B 19.94M 17.43M 16.08M 14.82M 27.94M 28.56M 192M 75.6M 940M 74.89M 73.24M 3.24B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/26 | ₹18,422.80 | -1.87% | 1,641 |
| 16/07/26 | ₹18,773.60 | -1.66% | 943 |
| 15/07/26 | ₹19,089.60 | +0.48% | 625 |
| 14/07/26 | ₹18,997.85 | -0.01% | 514 |
| 13/07/26 | ₹18,999.05 | -2.65% | 1,908 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NEULANDLAB Stock
Select your edition
All financial news and data tailored to specific country editions

















